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Jin Kwon Chung and Sung Jin Lee*Abstract
Background: To report a case of Streptococcus mitis/oralis endophthalmitis management which had developed
after complicated iris-fixated phakic intraocular (pIOL) lens implantation.
Case presentation: A 23-year-old-woman received pIOL implantation followed secondary intraocular intervention
to lower intraocular pressure. The patient presented with severe pain and decreased visual acuity and was managed
with intravitreal and intracameral antibiotic injection with topical applications of fortified antibiotics. Culture of
aqueous humor was positive for S. mitis/oralis, which was sensitive to the empiric antibiotic regimen. Clinical
features started to improve 5 days after treatment and the pIOL was left in place. The uncorrected distant visual
acuity and endothelial cell count were 20/32 and 3143cells/mm2 four weeks after treatment, respectively.
Conclusion: S. mitis/oralis endophthalmitis after pIOL implantation could be managed with appropriate antibiotic
administration without pIOL removal if accompanied by rapid clinical improvement after the initial intensive
management in the absence of vitreous involvement.
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Phakic intraocular lenses (pIOLs) are generally accepted
as effective and safe treatment options in the correction
of moderate to high myopia [1]. Different from LASER
assisted vision correction, a pIOL implantation into the
anterior or posterior chamber is a reversible operation.
This is a strong advantage of pIOL implantation, espe-
cially in the context of intra- or postoperative complica-
tion. However, intraocular surgery places patients at risk
for endophthalmitis, which could lead to permanent vis-
ual loss. Although the rate of endophthalmitis is lower
in pIOL implantation than in other types of intraocular
surgery such as phacoemulsification and posterior cham-
ber (PC) IOL implantation, early diagnosis and proper
management is still important in the management of this
potentially devastating complication [2,3]. We report a* Correspondence: wismile@schmc.ac.kr
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without pIOL removal.Case presentation
A 23-year-old-woman was referred to our hospital for
severe pain and decreased visual acuity started one day
ago in the right eye. Two days prior to this, the patient
had foldable iris-fixated pIOL (Artiflex; Ophtec BV,
Groningen, the Netherlands) implanted in both eyes at
an outside clinic. On postoperative day one, she had
undergone anterior chamber (AC) irrigation to remove
residual viscoelastics which caused intraocular pressure
(IOP) spike in the right eye.
On examination, uncorrected distant visual acuity
(UDVA) was hand motion with IOP of 21 mmHg for the
right eye. Biomicroscopy of the eye revealed severe con-
junctival injection, corneal edema, corneal infiltration at
superior main incision, membrane formation around the
pIOL, and a deep AC with a 1.5 mm hypopyon, whichral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(Figure 1A). Posterior segment evaluations such as vitre-
ous cell grading and fundus examination were impossible
because of severe corneal edema and AC inflammation.
B-scan ultrasonography showed no definite vitreous in-
volvement, and the left eye was normal.
Immediate management involved AC irrigation, obtain-
ing aqueous humor for culture and stain, and intravitreal
vancomycin (1.0 mg/0.1 cc) and amikacin (0.4 mg/0.1 cc)
injection. Gram and KOH stain smear revealed no bacteria
or fungus. The patient was also treated with systemic
(flomoxef 1.0 g every 12 hours) and topical (fortified
vancomycin (50 mg/mL) and amikacin (20 mg/mL)
hourly) antibiotics, prednisolone 1.0% four times daily,
and homatropine 2% twice daily eye drops for a week,
then the frequency was reduced according to the clinical
response, culture, and sensitivity results. After 5 days of
incubation, cultures became positive for Streptococcus
mitis/oralis. By day 2 of admission, the patient did not
improve so that AC irrigation, intracameral vancomycin
(1.0 mg/0.1 cc) and amikacin (0.4 mg/0.1 cc) injection,
and subtenon triamcinolone injection (40 mg/1.0 cc)
were performed.
After the second round of intervention, the patient
began to improve clinically. On day 5, UDVA improved
to 20/100, and biomicroscopy revealed moderate AC re-
action without hypopyon and decreased inflammatory
membrane behind the pIOL (Figures 1B, C). At 2 weeks,
UDVA was 20/40 and IOP was 11 mmHg (Figure 1D).Figure 1 Anterior segment photographs. A: Right eye shows conjunctiv
membrane formation around the phakic intraocular lens (pIOL), and a 1.5 m
chamber irrigation with intracameral antibiotic injection, the eye shows ma
intravitreal antibiotics injection, uncorrected distant visual acuity improvedEndothelial cell density was measured at 3143cells/mm2.
At 1 month, UDVA improved to 20/32, and biomicro-
scopy showed minimal AC reaction and corneal edema.
Conclusion
Infectious postoperative endophthalmitis is rare but
serious complication. Previously, there have been two
reported cases of endophthalmitis after iris-fixated
pIOL implantation. One case was of an Aspergillus en-
dophthalmitis, which was managed with pIOL removal,
lensectomty, and anterior vitrectomy with antifungal ad-
ministration [4]. A second case was caused by Streptococcus
pneumonia resulting in phthisis bulbi and was managed
through therapeutic keratoplasty, removal of the pIOL,
lensectomy, and repeated intravitreal injection of antibi-
otics [5]. For PC pIOL, the rate of endophthalmitis has
been reported as approximately 1 case of endophthalmi-
tis per 6000 implantable collamer lens implantation [2].
Oum et al. [6] reported Pseudomonas endophthalmitis
after PC pIOL implantation. That patient was managed
by removal of pIOL, lensectomy, vitrectomy with intra-
vitreal antibiotics injection, and demonstrated CDVA of
20/30 at the end of treatment. To our knowledge, this
report represents the first case of infectious endophthal-
mitis caused by S.mitis/oralis after iris-fixated pIOL
implantation.
S. mitis/oralis is an α-hemolytic gram-positive coccus
belonging to the viridians streptococcus group and is
commonly found in the oropharynx, gastrointestinalal injection, corneal edema with infiltrates at the corneal incision site,
m hypopyon 2 days after implantation. B, C: The day after anterior
rked decreased inflammation and corneal edema. D: At 2 weeks after
to 20/40 with a well-centered pIOL.
Chung and Lee BMC Ophthalmology 2014, 14:92 Page 3 of 3
http://www.biomedcentral.com/1471-2415/14/92tract, skin, and female genital tract [7]. It is considered
to have low virulence and pathogenicity but may cause
life-threatening infections, particularly endocarditis and
meningitis [7]. Recently, endophthalmitis outbreak of S.
mitis/oralis after intravitreal injection of bevacizumab
has been reported, and contamination during syringe
preparation of compounding pharmacy was found as
the cause, which implies that microbial contamination
could occur at any step of preparation or surgical proce-
dures [8]. The histopathologic finding of patient from
this outbreak showed a wide variety of severe pathologic
tissue changes and 7 of 12 (58.3%) eyes underwent encu-
cleation or evisceration [9]. Taken together, the virulence
and pathogenicity seem to be different on the tissue-by-
tissue or organ-by-organ basis.
Our patient had both complicated pIOL implantation
and secondary intervention. Complicated, prolonged
surgery and repeated intervention are known risk fac-
tors for infectious endophthalmitis. The patient in this
report achieved relatively favorable UDVA upon treat-
ment, which was different from previously published
cases [4–6]. S. mitis/oralis is less virulent than patho-
gens previously reported infections endophthalmitis,
and the antibiotic sensitivity tests revealed the bacteria
to be sensitive to vancomycin and flomoxef used in the
treatment. We did not remove the pIOL so that the pa-
tient could preserve UDVA. Although there were some
differences in surgical procedures, IOL removal is not
always recommended for post-cataract surgery endoph-
thalmitis [10]. However, it is usually difficult to identify
the source of infection. Moreover, clinical courses vary
across individual cases. If the pIOL is suspected to be an
infection source or the infection does not appear to clinic-
ally improve after intensive initial management, an imme-
diate removal should be considered.
Since AC irrigation, intracameral antibiotics injection
and systemic antibiotics administration were not proven
to be effective in management of postoperative infectious
endophthalmitis in a large prospective studies before, we
do not recommend our protocol to all the patients with
endophthalmitis after pIOL implantation and further stud-
ies with a large sample size should be necessary. Although
there was absent of IOP spike in our case, care should be
also taken to control IOP after a subtenon injection of a
long-acting corticosteroid in a young myopic patient.
Our report illustrates that S. mitis/oralis endophthal-
mitis can develop in patient who underwent complicated
iris-fixated pIOL implantation with additional intraocu-
lar intervention, and it can be managed with intravitreal
and intracameral antibiotics administrations without pIOL
removal. The case emphasizes the need for a high level of
clinical suspicion during evaluation of patients who have
undergone complicated surgery or received additional
intraocular intervention.Consent statement
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